相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL-33 induces ADAMTS5 expression and cell migration in glioblastoma multiforme
Dilara Akcora-Yildiz et al.
MEDICAL ONCOLOGY (2022)
Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition
Rohit Rao et al.
NEURO-ONCOLOGY (2022)
Inflammation and Myeloid Cells in Cancer Progression and Metastasis
Jenying Deng et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Sequential changes in histone modifications shape transcriptional responses underlying microglia polarization by glioma
Marta Maleszewska et al.
GLIA (2021)
ALKBH5 Facilitates Hypoxia-Induced Paraspeckle Assembly and IL8 Secretion to Generate an Immunosuppressive Tumor Microenvironment
Feng Dong et al.
CANCER RESEARCH (2021)
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Matthias Gromeier et al.
NATURE COMMUNICATIONS (2021)
Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells
Jiao Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
Gulcin Tezcan et al.
FRONTIERS IN IMMUNOLOGY (2021)
Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors
Lizhi He et al.
CELL REPORTS (2021)
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
Ester Gangoso et al.
CELL (2021)
p53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition
Touseef Sheikh et al.
CYTOKINE (2021)
Epigenetic Signaling of Cancer Stem Cells During Inflammation
Zaoqu Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells
Kui Zhail et al.
NATURE CANCER (2021)
Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment
Soohyun Hong et al.
THERANOSTICS (2021)
YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma
Krishanthan Vigneswaran et al.
CLINICAL CANCER RESEARCH (2021)
Imaging temozolomide-induced changes in the myeloid glioma microenvironment
Claudia Foray et al.
THERANOSTICS (2021)
SAA1 knockdown promotes the apoptosis of glioblastoma cells via downregulation of AKT signaling
Huikai Zhang et al.
JOURNAL OF CANCER (2021)
Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor
Jing-Yiing Wu et al.
MOLECULAR CELL (2020)
Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth
Maojin Yao et al.
CELL (2020)
Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma
Qiang-Wei Wang et al.
ONCOTARGETS AND THERAPY (2020)
The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
Max Huebner et al.
CANCERS (2020)
Tumor-associated macrophage interleukin-β promotes glycerol-3-phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells
Jian Lu et al.
CANCER SCIENCE (2020)
Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma
Carlos DeOcesano-Pereira et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes
Zhuo Chen et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Transcriptional, Epigenetic and Metabolic Programming of Tumor-Associated Macrophages
Irina Larionova et al.
CANCERS (2020)
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma
Wen-Bin Yang et al.
NEURO-ONCOLOGY (2020)
Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment
Anaelle A. Dumas et al.
EMBO JOURNAL (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
Syreeta DeCordova et al.
FRONTIERS IN IMMUNOLOGY (2020)
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
Trang Thi Thu Nguyen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression
Rui Yang et al.
BRITISH JOURNAL OF CANCER (2020)
The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy
Fiona A. Desland et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma
Inbar Angel et al.
ONCOGENE (2020)
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
Astrid De Boeck et al.
NATURE COMMUNICATIONS (2020)
HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and Macrophages
Mohammed Ghiboub et al.
FRONTIERS IN IMMUNOLOGY (2020)
Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors
Marjolein M. G. Kes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin et al.
DRUG RESISTANCE UPDATES (2020)
The hypoxia-lactate axis tempers inflammation
Lionel B. Ivashkiv
NATURE REVIEWS IMMUNOLOGY (2020)
ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
Luqing Tong et al.
THERANOSTICS (2020)
MGMT Status as a Clinical Biomarker in Glioblastoma
Madison Butler et al.
TRENDS IN CANCER (2020)
Brain immunology and immunotherapy in brain tumours
John H. Sampson et al.
NATURE REVIEWS CANCER (2020)
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases
Costas D. Arvanitis et al.
NATURE REVIEWS CANCER (2020)
TP53 gain-of-function mutation promotes inflammation in glioblastoma
Seok Won Ham et al.
CELL DEATH AND DIFFERENTIATION (2019)
GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling
Diana Matias et al.
MOLECULAR NEUROBIOLOGY (2019)
Blockade of NEAT1 represses inflammation response and lipid uptake via modulating miR-342-3p in human macrophages THP-1 cells
Lei Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth
Jonathan B. Lamano et al.
CLINICAL CANCER RESEARCH (2019)
Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
William Tomaszewski et al.
CLINICAL CANCER RESEARCH (2019)
Epigenetic modulation of metabolism in glioblastoma
Zhen Dong et al.
SEMINARS IN CANCER BIOLOGY (2019)
The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression
Weining Wu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Combined Inhibition of HDAC and EGFR Reduces Viability and Proliferation and Enhances STAT3 mRNA Expression in Glioblastoma Cells
Marienela Buendia Duque et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2019)
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma
Tanwir Hasan et al.
CELL DEATH & DISEASE (2019)
Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies
Marta Cenciarini et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Alberto Mantovani et al.
IMMUNITY (2019)
The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2/STAT3 pathway
Marina Couto et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The lncRNA Neat1 promotes activation of inflammasomes in macrophages
Pengfei Zhang et al.
NATURE COMMUNICATIONS (2019)
RelB acts as a molecular switch driving chronic inflammation in glioblastoma multiforme
Michael R. Waters et al.
ONCOGENESIS (2019)
IL-1 Family Members in Cancer; Two Sides to Every Story
Kevin J. Baker et al.
FRONTIERS IN IMMUNOLOGY (2019)
An Inflammatory Landscape for Preoperative Neurologic Deficits in Glioblastoma
Amal Katrib et al.
FRONTIERS IN GENETICS (2019)
Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages
Hao-Yu Chuang et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme
Zhenzhe Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Glioblastoma-Associated Microglia Reprogramming Is Mediated by Functional Transfer of Extracellular miR-21
Erik R. Abels et al.
CELL REPORTS (2019)
Molecular targeted therapy of glioblastoma
Emilie Le Rhun et al.
CANCER TREATMENT REVIEWS (2019)
PD-L1/PD-1 Axis in Glioblastoma Multiforme
Jakub Litak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
Christina Piperi et al.
CELLS (2019)
Tumor microenvironment: Interactions and therapy
Masoud Najafi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
Anna Wenger et al.
NEURO-ONCOLOGY (2019)
IL-33/ST2 axis promotes glioblastoma cell invasion by accumulating tenascin-C
Jian-fei Zhang et al.
SCIENTIFIC REPORTS (2019)
Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype
Giulia Stazi et al.
CLINICAL EPIGENETICS (2019)
Drugging DNA repair to target T-ALL cells
Yashodhara Dasgupta et al.
LEUKEMIA & LYMPHOMA (2018)
Targeting Epigenetics in Cancer
Richard L. Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis
Xin Cui et al.
BIOMATERIALS (2018)
The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages
Zsolt Czimmerer et al.
IMMUNITY (2018)
Histone methylation and acetylation in macrophages as a mechanism for regulation of inflammatory responses
Maria G. Daskalaki et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Multidimensional communication in the microenvirons of glioblastoma
Marike L. Broekman et al.
NATURE REVIEWS NEUROLOGY (2018)
MiR-223-3p overexpression inhibits cell proliferation and migration by regulating inflammation-associated cytokines in glioblastomas
Qiuping Ding et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Glioblastoma-activated pericytes support tumor growth via immunosuppression
Isadora F. G. Sena et al.
CANCER MEDICINE (2018)
Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies
Mony Chenda Morisse et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)
N6-methyladenine DNA Modification in Glioblastoma
Qi Xie et al.
CELL (2018)
The IFN-gamma/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
Jiawen Qian et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues
Dan Zhou et al.
GENOME BIOLOGY (2018)
Non-coding RNAs as drug targets
Masayuki Matsui et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Tumor-associated macrophages: from basic research to clinical application
Li Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment
Yatao Yin et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Cytoplasmic chromatin triggers inflammation in senescence and cancer
Zhixun Dou et al.
NATURE (2017)
The interplay between metabolic remodeling and immune regulation in glioblastoma
Pravin Kesarwani et al.
NEURO-ONCOLOGY (2017)
Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma
Xuechao Wu et al.
NEURO-ONCOLOGY (2017)
Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma
Spyros Darmanis et al.
CELL REPORTS (2017)
Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade
Changbin Zhu et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma
Yang Jiang et al.
CELL COMMUNICATION AND SIGNALING (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
Glioblastoma targeted therapy: updated approaches from recent biological insights
M. Touat et al.
ANNALS OF ONCOLOGY (2017)
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Zhihong Chen et al.
CANCER RESEARCH (2017)
Inflammatory landscape of human brain tumors reveals an NFκB dependent cytokine pathway associated with mesenchymal glioblastoma
Alfeu Zanotto-Filho et al.
CANCER LETTERS (2017)
m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program
Sicong Zhang et al.
CANCER CELL (2017)
Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain
Kristan E. van der Vos et al.
NEURO-ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway
Hao Xue et al.
AUTOPHAGY (2016)
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation
Bozena Kaminska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Lateral Thinking: How Histone Modifications Regulate Gene Expression
Moyra Lawrence et al.
TRENDS IN GENETICS (2016)
Interleukin-33 in human gliomas: Expression and prognostic significance
Dorothee Gramatzki et al.
ONCOLOGY LETTERS (2016)
5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients
Kevin C. Johnson et al.
NATURE COMMUNICATIONS (2016)
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Robert L. Bowman et al.
CELL REPORTS (2016)
Glioblastoma: pathology, molecular mechanisms and markers
Kenneth Aldape et al.
ACTA NEUROPATHOLOGICA (2015)
Cellular Metabolism and Macrophage Functional Polarization
Linnan Zhu et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2015)
MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia
Bing Cui et al.
BLOOD (2014)
IL-1β microenvironment promotes proliferation, migration and invasion of human glioma cells
K. Fathima Hurmath et al.
CELL BIOLOGY INTERNATIONAL (2014)
Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells
Kuan-Min Fang et al.
NEURO-ONCOLOGY (2014)
Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers
Adam L. Cohen et al.
BMC MEDICAL GENOMICS (2013)
MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways
N. Wu et al.
BRITISH JOURNAL OF CANCER (2013)
Interleukins in glioblastoma pathophysiology: implications for therapy
Y. T. Yeung et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Combined Targeting of PDK1 and EGFR Triggers Regression of Glioblastoma by Reversing the Warburg Effect
Kiran Kumar Velpula et al.
CANCER RESEARCH (2013)
β-defensin-3 negatively regulates TLR4-HMGB1 axis mediated HLA-G expression in IL-1β treated glioma cells
Piyushi Gupta et al.
CELLULAR SIGNALLING (2013)
Targeting lactate metabolism for cancer therapeutics
Joanne R. Doherty et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Interferon regulatory factor 3 alters glioma inflammatory and invasive properties
Leonid Tarassishin et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Epigenetic Regulation of the miR142-3p/Interleukin-6 Circuit in Glioblastoma
Guang-Yuh Chiou et al.
MOLECULAR CELL (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
Melody A. Swartz et al.
CANCER RESEARCH (2012)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation
Isabella Venza et al.
EPIGENETICS (2012)
The tumor microenvironment at a glance
Frances R. Balkwill et al.
JOURNAL OF CELL SCIENCE (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells
Yiu To Yeung et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Lactate: A Metabolic Key Player in Cancer
Franziska Hirschhaeuser et al.
CANCER RESEARCH (2011)
Janus head: the dual role of HLA-G in CNS immunity
Yu-Hwa Huang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Epigenetic Mechanisms in Inflammation
D. Bayarsaihan
JOURNAL OF DENTAL RESEARCH (2011)
Ras regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma
Vivek Sharma et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Non-coding RNAs in human disease
Manel Esteller
NATURE REVIEWS GENETICS (2011)
High Incidence of MGMT and RAR beta Promoter Methylation in Primary Glioblastomas: Association with Histopathological Characteristics, Inflammatory Mediators and Clinical Outcome
Christina Piperi et al.
MOLECULAR MEDICINE (2010)
Epigenetic changes in gliomas
Rebecca Burgess et al.
CANCER BIOLOGY & THERAPY (2008)
The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by toll-like receptor 4
Michael R. Chicoine et al.
NEUROSURGERY (2007)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
